Literature DB >> 18316701

Evidence of retinal function using microperimetry following autologous retinal pigment epithelium-choroid graft in macular dystrophy.

Fred K Chen1, Gurmit S Uppal, Gary S Rubin, Andrew R Webster, Peter J Coffey, Lyndon Da Cruz.   

Abstract

PURPOSE: To describe the outcomes of autologous retinal pigment epithelium (RPE)-choroid graft in macular dystrophy.
METHODS: In this prospective interventional case series, five patients with macular dystrophy were enrolled to undergo autologous RPE-choroid patch graft between August 2005 and January 2007. All patients received preoperative and postoperative evaluations including visual acuity, contrast sensitivity, reading ability, microperimetry, fluorescein angiography, indocyanine green angiography, fundus autofluorescence (AF) imaging, and optical coherence tomography (OCT).
RESULTS: Patients were followed up for an average of 13.4 (9-23) months. Two patients gained reading acuity but only one regained visual task function after graft. This was maintained for approximately 12 months. Although there is an overall loss of visual acuity, contrast sensitivity, and reading ability, postoperative microperimetry demonstrated retinal sensitivity over the graft in all patients with maximum sensitivity, using a Goldmann size III stimulus of 200-ms duration, ranging from 12 to 20 dB. After surgery, one patient developed retinal detachment and two required cataract extraction at the time of removal of oil. ICG angiography demonstrated perfusion of the graft in four patients. With image registration, homogenous AF pattern in areas of the graft was found to be associated with retinal sensitivity.
CONCLUSIONS: Autologous RPE-choroid graft can be performed in patients with macular dystrophy. Although microperimetry showed evidence of retinal function over a perfused and autofluorescent graft, the overall loss of visual acuity and reading ability raises concerns over the use of this novel surgical technique in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316701     DOI: 10.1167/iovs.07-1648

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE.

Authors:  Maria Kokkinaki; Niaz Sahibzada; Nady Golestaneh
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

2.  Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat.

Authors:  Amanda-Jayne Carr; Anthony A Vugler; Sherry T Hikita; Jean M Lawrence; Carlos Gias; Li Li Chen; David E Buchholz; Ahmad Ahmado; Ma'ayan Semo; Matthew J K Smart; Shazeen Hasan; Lyndon da Cruz; Lincoln V Johnson; Dennis O Clegg; Pete J Coffey
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

3.  Perfluorocarbon liquid assisted large retinal epithelium patching in sub-macular hemorrhage secondary to age related macular degeneration.

Authors:  S K Gibran; M R Romano; D Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-17       Impact factor: 3.117

Review 4.  Ophthalmic transplantology: posterior segment of the eye--part II.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-06

Review 5.  Induced pluripotent stem cell therapies for retinal disease.

Authors:  Oliver Comyn; Edward Lee; Robert E MacLaren
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

Review 6.  Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.

Authors:  Yesa Yang; Hannah Dunbar
Journal:  Ophthalmologica       Date:  2021-02-10       Impact factor: 3.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.